• SENSEX 81,481.86
    143.91 (+0.18%)
  • BANKNIFTY 56,150.70
    -71.30 (--0.13%)
  • CG Power & Ind
    666.90 874.50(%)
  • New India Assura
    207.25 302.80(%)
  • Vimta Labs
    623.60 235.00(%)
  • Jayaswal Neco
    54.06 55.34(%)
  • GNG Electronics
    364.00 364.00(%)
  • Tata Motors
    665.45 542.55(%)
  • Varun Beverages
    534.00 680.28(%)
  • Larsen & Toubro
    3,685.00 3,963.00(%)
  • Avenue Super.
    4,324.00 5,484.00(%)
  • Waaree Energies
    3,121.30 1,808.65(%)
  • HDB FINANC SER
    797.75 891.65(%)
  • Paradeep Phosph.
    205.30 78.75(%)
  • Bharti Airtel
    1,939.00 2,045.50(%)
  • Hitachi Energy
    21,350.00 21,350.00(%)
  • Godfrey Phillips
    9,526.50 9,824.00(%)
  • Reliance Industr
    1,401.35 1,115.55(%)
  • Indian Energy Ex
    138.50 244.35(%)
  • Zuari Agro Chem.
    296.90 296.90(%)
  • Ceinsys Tech
    1,760.40 2,105.00(%)
  • Hind Rectifiers
    2,001.15 2,001.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Aarti Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Alchemie Group
  • BSE Code : 2975.0
  • ISIN : INE767A01016
522.25 -17 (-3.12%)
  • As on 30 Jul 2025 (EOD)

  • Today’s Low

    513.80

  • Today’s High

    549.30

  • Open

    540.50

  • Perv Close

    539.05

  • 52W Low

    312.00

  • 52W High

    635.00

Key Indicators

  • P/E(TTM)

    26.83

  • Mar.Cap (₹Cr.)

    4,801.31

  • Div & Yield %

    0.19

  • Book Value(₹)

    136.18

  • Debt-Equity Ratio

    -3.12

  • AGM Date

    30-Jul-2025

  • EPS

    19.47

  • P/E Ratio

    26.83

Financials Ratios

  • Debt-Equity Ratio

    0.47

  • Mar.Cap (₹Cr.)

    4,801.31

  • RONW (%)

    13.87

  • ROCE (%)

    14.97

Score Board

  • Equity (₹ in Cr.)

    91.94

  • BV (₹)

    136.20

  • Sales( ₹ in Cr.)

    2,173.65

  • NP (in Cr.)

    157.31

  • NP Var(%)

    11.0

  • Div%

    10.0

  • CPS (₹)

    22.30

  • EPS (₹)

    17.10

  • Traded Value (₹ in Lakhs)

    4,803.14

  • 52 Week High

    635.00

  • 52 Week Low

    312.00

  • Price BSE

    522.0

  • Price NSE

    522.00

  • Market Capital( in Cr.)

    4,803.14

  • P/C Ratio

    23.40

  • P/E Ratio

    30.50

  • Price Vs.BV

    17.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 2,266.91 2,497.97 2,251.17 1,914.89 1,634.92 1,454.25
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,266.91 2,497.97 2,251.17 1,914.89 1,634.92 1,454.25
Other Income 4.18 2.23 4.77 9.69 9.44 6.28
Stock Adjustments -26.77 6.72 77.94 9.08 53.94 -19.05
Total Income 2,244.32 2,506.92 2,333.88 1,933.66 1,698.30 1,441.48
EXPENDITURE :            
Raw Materials 1,476.42 1,723.25 1,558.47 1,148.99 1,099.82 945.98
Power and Fuel Cost 151.64 153.45 126.05 95.64 101.04 82.14
Employee Cost 70.20 64.30 57.17 55.60 52.65 47.23
Other Manufacturing Expenses 191.24 182.71 171.26 138.99 122.62 103.91
Selling and Administration Expenses 73.95 89.25 89.75 76.70 59.39 50.37
Miscellaneous Expenses 7.52 5.68 5.24 6.72 5.40 2.83
Employee Benefit Expenses 70.20 64.30 57.17 55.60 52.65 47.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,970.96 2,218.64 2,007.95 1,522.64 1,440.92 1,232.46
Operating Profit 273.36 288.28 325.94 411.02 257.38 209.02
Interest 33.21 36.18 23.05 25.71 35.74 41.00
Gross Profit 240.15 252.10 302.89 385.31 221.64 168.02
Depreciation 47.67 47.29 47.39 47.60 46.67 40.39
Profit Before Tax 192.48 204.81 255.50 337.71 174.97 127.63
Current Tax 49.60 53.25 65.50 84.50 49.55 31.92
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.00 -1.25 -5.00 -4.50 -10.25 8.45
Reported Net Profit 141.88 152.81 195.00 257.71 135.67 87.26
Extraordinary Items 0.00 0.00 0.00 0.17 6.35 2.54
Adjusted Net Profit 141.88 152.81 195.00 257.54 129.32 84.72
Adjustment below Net Profit -13.32 0.00 -51.64 -69.90 -26.90 -0.48
P & L Balance brought forward 947.13 818.86 704.26 565.52 475.07 399.36
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 23.38 24.54 28.76 49.07 18.32 11.06
P & L Balance carried down 1,052.31 947.13 818.86 704.26 565.52 475.07
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 25.00 20.00 10.00
Dividend Per Share(Rs) 1.00 1.00 1.00 2.50 2.00 1.00
Earnings Per Share-Unit Curr 15.43 16.50 21.06 27.65 58.23 37.00
Earnings Per Share(Adj)-Unit Curr 15.43 16.50 21.06 27.65 14.56 9.25
Book Value 127.83 120.34 104.99 92.23 266.86 219.90
Book Value(Adj)-Unit Curr 127.83 120.34 104.99 92.23 66.72 54.97

Shareholding Pattern

  • Promoter Group

    55.22%

  • Public Share Holding

    44.78%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 12,520,770 13.72 12,520,770 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37,882,932 41.51 37,882,932 30
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 50,403,702 55.22 50,403,702 41
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 16 0.00 16 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,063,132 2.26 2,063,132 61
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 70,214 0.08 70,214 1
Mutual Funds / UTI 8,985,840 9.85 8,985,840 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,651 0.01 11,651 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,130,853 12.20 11,130,853 73
2] Non Institution
Bodies Corporate 737,268 0.81 737,267 335
Clearing Members 745 0.00 745 6
Directors of their Relatives 4,953,290 5.43 4,951,090 8
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 603,429 0.66 603,429 2,103
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 645,010 0.71 645,010 3,479
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,788,856 6.34 5,756,856 73
Individuals holding nominal share capital up to Rs. 1 lakh 15,834,382 17.35 15,276,663 154,092
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 287 0.00 287 2
Others 1,005,397 1.10 1,005,397 5
Sub Total 29,735,445 32.58 29,143,525 160,146
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 91,270,000 100.00 90,678,080 160,260

Company Background

Aarti Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Aarti Drugs Ltd
  • BSE Code : 2975.0
  • ISIN : INE767A01016

  • Incorporation Year

    1984

  • Registered Office

    Plot No N-198 MIDC Tarapur
    Pamtembhi Village Palghar Tal, Thane,
    Maharashtra-401506

  • Telephone

    91-22-24072249

  • FAX

    91-22-24073462/24070144

  • Chairman

    C V Gogri

  • Managing Director

    Rashesh C Gogri

  • Company Secretary

    Rushikesh Deole

  • Auditor

    Gokhale & Sathe

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Aarti Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Aarti Drugs 522.45 2,271.09 2,266.91 26.83 13.65
Abbott India 35,188.85 6,684.73 6,409.15 52.87 44.95
Astrazeneca Phar 9,291.00 1,756.92 1,716.29 200.67 32.94
P & G Health Ltd 5,950.15 1,166.89 1,151.26 39.32 39.76
Glaxosmi. Pharma 3,194.70 3,866.05 3,723.49 58.89 58.72
Cipla 1,559.80 20,029.57 19,044.85 23.31 21.40
Amrutanjan Healt 664.40 437.58 421.23 37.79 20.84
Guj. Themis Bio. 388.35 174.19 169.82 86.69 44.82
Fermenta Biotec. 376.85 442.21 430.53 16.41 17.61
Bliss GVS Pharma 184.05 703.42 667.20 27.51 9.16
Ambalal Sarabhai 33.09 19.33 4.04 30.64 2.10